Neogen Corporation (NEOG)

Market Cap	2.15B
Revenue (ttm)	880.32M
Net Income (ttm)	-602.74M
Shares Out	217.53M
EPS (ttm)	-2.78
PE Ratio	n/a
Forward PE	35.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,578,620
Open	9.32
Previous Close	9.35
Day's Range	9.32 - 9.93
52-Week Range	3.87 - 12.07
Beta	1.95
Analysts	Buy
Price Target	10.67 (+8.11%)
Earnings Date	Jan 8, 2026

About NEOG

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanita...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 23, 1989
• Employees: 2,974
• Stock Exchange: NASDAQ
• Ticker Symbol: NEOG
• Website: https://www.neogen.com

Financial Performance

In 2025, Neogen's revenue was $894.66 million, a decrease of -3.20% compared to the previous year's $924.22 million. Losses were -$1.09 billion, 11491.6% more than in 2024.

Analyst Summary

According to 4 analysts, the average rating for NEOG stock is "Buy." The 12-month stock price target is $10.67, which is an increase of 8.11% from the latest price.

Price Target

$10.67

(8.11% upside)

Analyst Consensus: Buy